0000899243-18-019862.txt : 20180713 0000899243-18-019862.hdr.sgml : 20180713 20180713200030 ACCESSION NUMBER: 0000899243-18-019862 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180712 FILED AS OF DATE: 20180713 DATE AS OF CHANGE: 20180713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelbon Marcia S. CENTRAL INDEX KEY: 0001472163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34475 FILM NUMBER: 18953417 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEROS CORP CENTRAL INDEX KEY: 0001285819 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911663741 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-676-5000 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-12 0 0001285819 OMEROS CORP OMER 0001472163 Kelbon Marcia S. 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 0 1 0 0 VP Patent and General Counsel Common Stock 2018-07-12 4 M 0 4277 4.10 A 188922 D Common Stock 2018-07-12 4 S 0 4277 21.4838 D 184645 D Stock Option (Right to Buy) 4.10 2018-07-12 4 M 0 4277 0.00 D 2022-01-07 Common Stock 4277 83252 D Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, and amended on May 17, 2018. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This transaction was executed in multiple trades at prices ranging from $21.46 to $21.49; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011. /s/ Marcia S. Kelbon 2018-07-13